Apotea AB Statistics

Total Valuation

Apotea AB has a market cap or net worth of SEK 7.63 billion. The enterprise value is 7.87 billion.

Market Cap	7.63B
Enterprise Value	7.87B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Apotea AB has 104.07 million shares outstanding. The number of shares has increased by 0.62% in one year.

Current Share Class	n/a
Shares Outstanding	104.07M
Shares Change (YoY)	+0.62%
Shares Change (QoQ)	+1.17%
Owned by Insiders (%)	0.45%
Owned by Institutions (%)	54.46%
Float	68.20M

Valuation Ratios

The trailing PE ratio is 35.00 and the forward PE ratio is 35.09.

PE Ratio	35.00
Forward PE	35.09
PS Ratio	1.15
PB Ratio	12.41
P/TBV Ratio	13.51
P/FCF Ratio	175.87
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.90, with an EV/FCF ratio of 181.29.

EV / Earnings	36.61
EV / Sales	1.20
EV / EBITDA	19.90
EV / EBIT	29.60
EV / FCF	181.29

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.38.

Current Ratio	1.16
Quick Ratio	0.49
Debt / Equity	0.38
Debt / EBITDA	0.61
Debt / FCF	5.58
Interest Coverage	50.15

Financial Efficiency

Return on equity (ROE) is 39.96% and return on invested capital (ROIC) is 21.23%.

Return on Equity (ROE)	39.96%
Return on Assets (ROA)	11.21%
Return on Invested Capital (ROIC)	21.23%
Return on Capital Employed (ROCE)	35.59%
Revenue Per Employee	7.87M
Profits Per Employee	258,604
Employee Count	831
Asset Turnover	4.41
Inventory Turnover	10.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	76.81
200-Day Moving Average	n/a
Relative Strength Index (RSI)	40.34
Average Volume (20 Days)	93,577

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Apotea AB had revenue of SEK 6.54 billion and earned 214.90 million in profits. Earnings per share was 2.10.

Revenue	6.54B
Gross Profit	1.25B
Operating Income	265.80M
Pretax Income	264.70M
Net Income	214.90M
EBITDA	341.40M
EBIT	265.80M
Earnings Per Share (EPS)	2.10

Full Income Statement

Balance Sheet

The company has 27.30 million in cash and 242.00 million in debt, giving a net cash position of -214.70 million or -2.06 per share.

Cash & Cash Equivalents	27.30M
Total Debt	242.00M
Net Cash	-214.70M
Net Cash Per Share	-2.06
Equity (Book Value)	636.00M
Book Value Per Share	5.91
Working Capital	140.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 206.20 million and capital expenditures -162.80 million, giving a free cash flow of 43.40 million.

Operating Cash Flow	206.20M
Capital Expenditures	-162.80M
Free Cash Flow	43.40M
FCF Per Share	0.42

Full Cash Flow Statement

Margins

Gross margin is 19.13%, with operating and profit margins of 4.06% and 3.29%.

Gross Margin	19.13%
Operating Margin	4.06%
Pretax Margin	4.05%
Profit Margin	3.29%
EBITDA Margin	5.22%
EBIT Margin	4.06%
FCF Margin	0.66%

Dividends & Yields

Apotea AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.62%
Shareholder Yield	-0.62%
Earnings Yield	2.82%
FCF Yield	0.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Apotea AB has an Altman Z-Score of 10.37.

Altman Z-Score	10.37
Piotroski F-Score	n/a